FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Jarosinski

Research Profile

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Victor E Barrios; Mark Jarosinski; Clifford D Wright
Proteinase-activated receptor-2 mediates hyperresponsiveness in isolated guinea pig bronchi.
Christopher Fotsch; Duncan M Smith; Jeffrey A Adams; Janet Cheetham; Michael Croghan; Elizabeth M Doherty; Clarence Hale; Mark Jarosinski; Michael G Kelly; Mark H Norman; Nuria A Tamayo; Ning Xi; James W Baumgartner
Design of a new peptidomimetic agonist for the melanocortin receptors based on the solution structure of the peptide ligand, Ac-Nle-cyclo[Asp-Pro-DPhe-Arg-Trp-Lys]-NH(2).
Anthony W Bannon; J Seda; Michelle Carmouche; J M Francis; Mark Jarosinski; J Douglass
Multiple behavioral effects of cocaine- and amphetamine-regulated transcript (CART) peptides in mice: CART 42-89 and CART 49-89 differ in potency and activity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Jarosinski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Victor E Barrios; Mark Jarosinski; Clifford D Wright
Proteinase-activated receptor-2 mediates hyperresponsiveness in isolated guinea pig bronchi.
Biochemical pharmacology 2003;66(3):519-25.
2003: Christopher Fotsch; Duncan M Smith; Jeffrey A Adams; Janet Cheetham; Michael Croghan; Elizabeth M Doherty; Clarence Hale; Mark Jarosinski; Michael G Kelly; Mark H Norman; Nuria A Tamayo; Ning Xi; James W Baumgartner
Design of a new peptidomimetic agonist for the melanocortin receptors based on the solution structure of the peptide ligand, Ac-Nle-cyclo[Asp-Pro-DPhe-Arg-Trp-Lys]-NH(2).
Bioorganic & medicinal chemistry letters 2003;13(14):2337-40.
2001: Anthony W Bannon; J Seda; Michelle Carmouche; J M Francis; Mark Jarosinski; J Douglass
Multiple behavioral effects of cocaine- and amphetamine-regulated transcript (CART) peptides in mice: CART 42-89 and CART 49-89 differ in potency and activity.
The Journal of pharmacology and experimental therapeutics 2001;299(3):1021-6.
2000: Anja Leona Biere; Stephen J Wood; Jette Wypych; Shirley Steavenson; Y Jiang; D Anafi; F W Jacobsen; Mark Jarosinski; GM Wu; Jean-Claude Louis; F Martin; Linda O Narhi; Martin Citron
Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs.
The Journal of biological chemistry 2000;275(44):34574-9.
2000: TJ Zamborelli; W S Dodson; B J Harding; J Zhang; BD Bennett; D M Lenz; Yunjen Young; Mitsuru Haniu; C F Liu; T Jones; Mark Jarosinski
A comparison of folding techniques in the chemical synthesis of the epidermal growth factor-like domain in neu differentiation factor alpha/beta.
The journal of peptide research : official journal of the American Peptide Society 2000;55(5):359-71.
1999: Robert Vassar; BD Bennett; Safura Babu-Khan; S Kahn; E A Mendiaz; Paul E Denis; David B Teplow; S Ross; P Amarante; R Loeloff; Y Luo; S Fisher; J Fuller; S Edenson; Jack Lile; Mark Jarosinski; Anja Leona Biere; E Curran; TL Burgess; Jean-Claude Louis; F Collins; James J S Treanor; G Rogers; Martin Citron
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
Science (New York, N.Y.) 1999;286(5440):735-41.
1999: C Lee; Flavia Piazza; Siska Brutsaert; J Valens; I Strehlow; Mark Jarosinski; C Saris; Christian Schindler
Characterization of the Stat5 protease.
The Journal of biological chemistry 1999;274(38):26767-75.
1999: Peter Ettmayer; Dennis Stanley France; JS Gounarides; Mark Jarosinski; MS Martin; J M Rondeau; Michael Sabio; S Topiol; B Weidmann; M Zurini; Kenneth W Bair
Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1).
Journal of medicinal chemistry 1999;42(6):971-80.
1998: Thorsten Dieckmann; E S Withers-Ward; Mark Jarosinski; C F Liu; I S Chen; Juli Feigon
Structure of a human DNA repair protein UBA domain that interacts with HIV-1 Vpr.
Nature structural biology 1998;5(12):1042-7.
1998: J P Mayer; J Zhang; Stefan Gröger; C F Liu; Mark Jarosinski
Lanthionine macrocyclization by in situ activation of serine.
The journal of peptide research : official journal of the American Peptide Society 1998;51(6):432-6.
1993: Mark Jarosinski; P S Reddy; W K Anderson
Synthesis, chemical reactivity, and antitumor evaluation of congeners of carmethizole hydrochloride, an experimental "acylated vinylogous carbinolamine" tumor inhibitor.
Journal of medicinal chemistry 1993;36(23):3618-27.